Home › Studies › PRJNA477357
PRJNA477357 SRP151052

Gut microbiome in X-linked SCID patients post gene therapy

Microbiome in Severe Combined Immunodeficiency (X-linked)

116 samples (USA and France) from a longitudinal cohort/case series study assessing gut microbial community changes in SCID patients following gene therapy and immune reconstitution. machine-written summary

116 samples · 122 runs · US, FR · Infant / toddler · 2018 · 0.99 Gbp / sample

Sources
✓Sequence archive 780○Abstract / description○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive780 sample values (collection date, country, health condition, health condition detail, intervention, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC6161392
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

before · no interventionbefore · no interventi21 samplesotherother95 samples
single arm: samples before and on the intervention

design single_arm_before_after · Gene therapy and immune reconstitution in SCID patients, pre/post sampling

Samples at a glance
2 countries
Age
unknown116
Condition
transplant_or_immunocompromised95
healthy_control21
Country
US112
FR4
Body site
primary77
excluded39
Collected 2010–2014
2010: 6 samples2011: 19 samples2012: 62 samples2013: 1 samples2014: 12 samples20102014
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 26 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 4 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 4 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 22 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 56 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 4 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 1.06 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

9 of 12 people sampled more than once (74 samples; median 5, up to 21 per person) · follow-up median 7 mo (max 9 mo) · median interval between samples 2 mo (time from collection dates). Schedule stated by the source: “archive time labels: 1, 2, 4, 3, 5, 7, 6, 8” (time origin: intervention_start).

F201F201: day 0F201: day 0F201: day 0F201: day 260U207U207: day 0U207: day 43U207: day 79U207: day 1840 d2 mo4 mo6 mo9 mo

Each row is one person (2 shown of 9); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Veillonella 14.7%Akkermansia 13.6%Bifidobacterium 13.5%Escherichia 10.1%Staphylococcus 6.8%Bacteroides 6.0%Citrobacter 5.0%Ruthenibacterium 3.3%Enterocloster 2.7%Mediterraneibacter 2.5%Enterococcus_B 2.2%Flavonifractor 1.8%not assigned to a genus 3.6%other genera 14.2%

Genera, mean relative abundance over 62 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country116 100%116
health_condition116 100%116
subject_id116 100%116
health_condition_detail116 100%116
intervention116 100%116
collection_date100 86%100
timepoint_label100 86%100
Papers (1)
  • T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. 2018 PMID 30261899 PMC6161392 own_data
Details
Archive description

Assessing changes in the microbial community of SCID patients after gene therapy and immune reconstitution.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of infant / toddler by opus_adjudicated with confidence 0.40. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host study.description · “SCID patients after gene therapy”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN09467083collection_date2012-01-01R10.85biosample.attribute:collection_date2012-01-01
SAMN09467083countryUSR10.90biosample_attrUSA
SAMN09467083health_conditionhealthy_controlR10.85biosample.attribute:study_groupHealthy
SAMN09467083health_condition_detailHealthyR10.85biosample.attribute:study_groupHealthy
SAMN09467083interventionno_interventionR10.85biosample.attribute:study_groupHealthy
SAMN09467083subject_idHC01R10.85biosample_attrHC01
SAMN09467083timepoint_label1R10.80biosample_attr1
Sequencing

122 runs over 116 samples · mean 1.15 Gbp per run (median 0.99 Gbp, total 139.84 Gbp; 122 runs with a base count) · layout PAIRED 122 · platform ILLUMINA 122 · models Illumina HiSeq 2500 (122) · 64% of runs with a Sandpiper profile · first public 2018-06-26

Authors (0)

No author record.

Downloads

PRJNA477357.csv.gz (4.2 KB) · parquet (75.3 KB) — all 116 samples, every field with route and confidence · PRJNA477357_determinations.csv.gz (4.9 KB) — 780 evidence rows

Samples (116 · every field this project has values for · hover a cell for its source)
Loading the sample table…